Shreya Nandi, Sohini Das

Stories by Shreya Nandi, Sohini Das

India's spice exports at potential risk, needs urgent action: GTRI

India's spice exports at potential risk, needs urgent action: GTRI

Rediff.com   2 May 2024

Countries that raised concerns about the quality of Indian spices have called for urgent attention and action, Delhi-based think tank Global Trade Research Initiative (GTRI) said on Wednesday. The stakes are high since India exported spices worth about $692.5 million to the United States (US), Hong Kong, Singapore, Australia and Maldives in the financial year 2023-24 (FY24), it said. During FY24, India's spice exports were worth $4.25 billion, accounting for a 12 per cent share of the global spice exports.

Taiwan keen to help India become leader in chip space

Taiwan keen to help India become leader in chip space

Rediff.com   29 Apr 2024

Taiwan is keen to collaborate with India and help it become a leader in the semiconductor space, Jason Ho, chairman of the Taiwan Chamber of Commerce in India, said, asserting that the Taiwanese companies have the supply chain for things that the Indian market needs. Manufacturing semiconductors - used in electric and hybrid cars, drones, and communication devices - is fairly complicated, entails huge investment, and can be a cumbersome process.

Basmati rice exports rose 22% till February FY24 on West Asia demand

Basmati rice exports rose 22% till February FY24 on West Asia demand

Rediff.com   28 Apr 2024

Exports of high-quality basmati rice from India grew by 22 per cent to $5.2 billion during April 2023-February 2024, amid robust demand, primarily from West Asia. According to data compiled by the commerce department, exports of basmati rice increased to 4.68 million metric tonnes (MMT) in April-February, from 4.1 MMT during the same period a year ago, registering a growth of 14 per cent.

Quality Control Orders: What does this mean for domestic industry?

Quality Control Orders: What does this mean for domestic industry?

Rediff.com   25 Apr 2024

From toys, footwear and furniture to insulated flasks, smart meters, and air coolers - the Central government over the last decade has mandated higher standards for production and imports of such items. Sample this: Till 2014, there were 14 Quality Control Orders (QCOs) covering 106 products. By the latest count, there are 156 QCOs on 672 products.

Gut Health Key To Prevent Chronic Illnesses

Gut Health Key To Prevent Chronic Illnesses

Rediff.com   24 Apr 2024

Maintaining the balance of gut microbiota is important as an imbalance, also known as dysbiosis, can cause or aggravate different diseases, including but not limited to digestive problems such as inflammatory bowel syndrome, mental health issues like anxiety and depression and menstrual problems.

Zydus gets China nod for kidney disease drug

Zydus gets China nod for kidney disease drug

Rediff.com   24 Apr 2024

Ahmedabad-based Zydus Lifesciences said on Tuesday that a new drug application for its oral drug Desidustat used in treating anaemia in chronic kidney disease (CKD) patients had been accepted by the National Medical Products Administration of China (NMPA). In 2020, CMS International Development and Management Ltd, a wholly-owned subsidiary of China Medical System Holdings Ltd obtained an exclusive license for the product from Zydus. CKD involves a gradual loss of functioning of kidneys and eventually leads to kidney failure.

Centre in a huddle to understand impact of the Iran-Israel tensions

Centre in a huddle to understand impact of the Iran-Israel tensions

Rediff.com   16 Apr 2024

Top government officials in New Delhi have started discussions with stakeholders ranging from shipping and container companies to export promotion councils to understand the impact of the Iran-Israel tensions and plan ahead. Inter-ministerial talks are also being lined up amid the crisis situation in West Asia, sources confirmed. While the crude flows are not directly under any threat, elevated oil prices remain a concern, according to officials.

Consumption story gets a facelift as rural demand shows promise

Consumption story gets a facelift as rural demand shows promise

Rediff.com   16 Apr 2024

Consumer goods firms and auto companies are witnessing an upturn in rural demand, which had been lagging for most of FY24. Expectations of a bumper rabi crop harvest have helped turn the tide. The Reserve Bank of India's (RBI's) Monetary Policy Committee kept the repo rate unchanged last week, noting that as rural demand catches up, consumption is expected to support economic growth in 2024-25.

Nearly one in two luxury cars sold in March quarter was Mercedes Benz

Nearly one in two luxury cars sold in March quarter was Mercedes Benz

Rediff.com   12 Apr 2024

Nearly one in two luxury cars sold in India in the first three months of 2024 was a Mercedes Benz, which achieved its best ever quarter (January-March), selling 5,412 units, up 15 per cent year-on-year (Y-o-Y) from 4,697 units in the previous year.

Officials Prepare For Modi 3.0

Officials Prepare For Modi 3.0

Rediff.com   12 Apr 2024

Government departments have been tasked with identifying major goals, which will include annual targets from the financial year 2024-2025 to 2028-2029.

Why Drug Prices Won't Increase This Year

Why Drug Prices Won't Increase This Year

Rediff.com   5 Apr 2024

The government has been stringent with pricing changes. Prices of 651 essential medicines came down from April 1, 2023 by 6.73 per cent with the government capping ceiling prices of these drugs.

Why Hospital Stays Are Getting Shorter

Why Hospital Stays Are Getting Shorter

Rediff.com   3 Apr 2024

'Every hospital now tracks length of stay closely.' 'More efficiency is brought into the system now.'

Bajaj Auto to pump Rs 3,000 crore into finance subsidiary

Bajaj Auto to pump Rs 3,000 crore into finance subsidiary

Rediff.com   1 Apr 2024

Bajaj Auto, India's leading two-wheeler (2W) and three-wheeler (3W) maker, is scaling up its wholly owned finance subsidiary, Bajaj Auto Credit Ltd (BACL), with an investment of more than Rs 3,000 crore planned over the next two financial years, company's managing director Rajiv Bajaj said. BACL has already started commercial operations, Bajaj recently said on the sidelines of the group's CSR identity event. According to rating agency CRISIL, BACL's operations began on January 1 after receiving its licence from the Reserve Bank of India (RBI) in August last year.

Frontline Relive Pandemic Nightmare

Frontline Relive Pandemic Nightmare

Rediff.com   1 Apr 2024

Battling the virus, enduring separation from loved ones, and working extended hours became part of the job.

Indian pharma companies bank on 'mother brands' to boost revenue growth

Indian pharma companies bank on 'mother brands' to boost revenue growth

Rediff.com   28 Mar 2024

Indian pharma companies are focussing on flagship products or mother brands under which they launch various new combinations to ensure robust revenue growth as well as therapy leadership. An analysis by market research firm Pharmarack showed how such flagship brands have posted strong growth CAGR in the last five years, with some even doubling sales. Sheetal Sapale, vice-president, commercial at Pharmarack, said, "Mother brands are analogous to an aggressive player who has put in a lot of effort during the prime years of life but now continues to silently nurture the brand family to collectively cross newer benchmarks of success."

Skoda to drive in Brezza, Sonet rival in H1FY25

Skoda to drive in Brezza, Sonet rival in H1FY25

Rediff.com   28 Feb 2024

koda Auto India is set to drive in a new car by the first half of next year to reach its target of 100,000 unit annual sales in the country by 2026. The compact sports utility vehicle (SUV) will be positioned against the likes of Maruti Brezza, Hyundai Venue, and Kia Sonet, and would be competitively priced, a senior company official said. koda will also export the car to right-hand-drive markets like Australia, New Zealand and the Asean nations.

'The formulations business been a growth driver'

'The formulations business been a growth driver'

Rediff.com   24 Feb 2024

'However, we have seen weakness in our active pharmaceutical ingredients business.'

Revamped SEZ law unlikely before the upcoming Lok Sabha elections

Revamped SEZ law unlikely before the upcoming Lok Sabha elections

Rediff.com   24 Feb 2024

The revamped Special Economic Zone (SEZ) law is unlikely to see the light of the day before the upcoming Lok Sabha elections, two people aware of the matter said. The commerce department had sought the Union Cabinet's nod to bring amendments to the existing SEZ Act, 2005 late last year. The plan, thereafter, was to introduce the Bill in the winter session of Parliament. Cabinet's approval remains pending.

PMO Monitoring Red Sea Crisis

PMO Monitoring Red Sea Crisis

Rediff.com   16 Feb 2024

Any government support or incentive to help exporters deal with high freight and insurance costs is unlikely.

Tax poser in the way of Hyundai local arm listing

Tax poser in the way of Hyundai local arm listing

Rediff.com   15 Feb 2024

South Korean auto giant Hyundai Motor Company is considering tax implications of listing its Indian unit before taking a final call, according to sources privy to the development. Hyundai Motor is mulling an initial public offering (IPO) for its Indian arm to raise around $3 billion (at a valuation of up to $30 billion), and talks are in the early stages between the company and bankers, banking sources revealed. Hyundai Motor India Ltd (HMIL), however, declined to comment on the development.